I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Staszewski, S
262
results:
Search for persons
X
Format
Online (262)
Mediatypes
E-Books (2)
Articles (Online) (126)
Bookchapter (Online) (21)
OpenAccess-fulltext (113)
Languages
german (13)
english (228)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy, adherence and tolerability of once daily tenofovi..:
Esser, S
;
Haberl, A
;
Mulcahy, F
...
European Journal of Medical Research. 16 (2011) 10 - p. 427 , 2011
Link:
https://doi.org/10.1186/..
?
2
Intensification of a failing regimen with zidovudine may ca..:
Stephan, C.
;
Dauer, B.
;
Bickel, M.
...
Journal of Infection. 61 (2010) 4 - p. 346-350 , 2010
Link:
https://doi.org/10.1016/..
?
3
The influence of HAART on the efficacy and safety of pegyla..:
Vogel, M
;
Ahlenstiel, G
;
Hintsche, B
...
European Journal of Medical Research. 15 (2010) 3 - p. , 2010
Link:
https://doi.org/10.1186/..
?
4
Human immunodeficiency virus type-1 group M quasispecies ev..:
Biru, T.
;
Lennemann, T.
;
Stürmer, M.
...
Medical Microbiology and Immunology. 199 (2010) 4 - p. 323-332 , 2010
Link:
https://doi.org/10.1007/..
?
5
Mutations in the C-terminal region of the HIV-1 reverse tra..:
Michels, I
;
Staszewski, S
;
Gürtler, L
...
European Journal of Medical Research. 15 (2010) 10 - p. 415 , 2010
Link:
https://doi.org/10.1186/..
?
6
Lipometabolic side-effects of three ritonavir-boosted doubl..:
Wendig, A
;
Stephan, C
;
Khaykin, P
...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P122 , 2008
Link:
https://doi.org/10.1186/..
?
7
Virological and immunological response to three boosted pro..:
Baumgardt, C
;
Stephan, C
;
Haberl, AE
...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P32 , 2008
Link:
https://doi.org/10.1186/..
?
8
Both long-term HIV infection and highly active antiretrovir..:
Lorenz, M.W.
;
Stephan, C.
;
Harmjanz, A.
...
Atherosclerosis. 196 (2008) 2 - p. 720-726 , 2008
Link:
https://doi.org/10.1016/..
?
9
Infektionen durch intravasale Katheter:
Staszewski, S.
;
Dimas, K.
;
Stille, W.
DMW - Deutsche Medizinische Wochenschrift. 110 (2008) 2 - p. 43-47 , 2008
Link:
https://doi.org/10.1055/..
?
10
3OD – Once-daily (OD) TDF-containing HAART in HIV-1-infecte..:
Esser, S
;
Staszewski, S
;
Haberl, AE
...
Journal of the International AIDS Society. 11 (2008) Suppl 1 - p. P76 , 2008
Link:
https://doi.org/10.1186/..
?
11
The steady-state pharmacokinetics of atazanavir/ritonavir i..:
von Hentig, N.
;
Babacan, E.
;
Lennemann, T.
...
Journal of Antimicrobial Chemotherapy. 62 (2008) 3 - p. 579-582 , 2008
Link:
https://doi.org/10.1093/..
?
12
Factors associated with viral rebound among highly treatmen..:
Smith, CJ
;
Phillips, AN
;
Dauer, B
...
HIV Medicine. 10 (2008) 1 - p. 19-27 , 2008
Link:
https://doi.org/10.1111/..
?
13
[636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATME..:
Rockstroh, J.K.
;
Ahlenstiehl, G.
;
Vogel, M.
...
Journal of Hepatology. 46 (2007) - p. S240 , 2007
Link:
https://doi.org/10.1016/..
?
14
Predictors of Virological Outcome and Safety in Primary HIV..:
Hoen, B.
;
Cooper, D. A.
;
Lampe, F. C.
...
Clinical Infectious Diseases. 45 (2007) 3 - p. 381-390 , 2007
Link:
https://doi.org/10.1086/..
?
15
Drug Resistance to Tipranavir (TPV) or Darunavir (DRV) Acco..:
STUERMER, M
;
DAUER, B
;
HABERL, A
...
Antiviral Research. 74 (2007) 3 - p. A29-A29 , 2007
Link:
https://doi.org/10.1016/..
1-15